The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury

Idiopathic Pulmonary Fibrosis (IPF) is a chronic lung disease characterized by scar formation and respiratory insufficiency, which progressively leads to death. Pulmonary hypertension (PH) is a common complication of IPF that negatively impacts clinical outcomes, and has been classified as Group III...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Anandharajan Rathinasabapathy, Alana Horowitz, Kelsey Horton, Ashok Kumar, Santhi Gladson, Thomas Unger, Diana Martinez, Gaurav Bedse, James West, Mohan K. Raizada, Ulrike M. Steckelings, Colin Sumners, Michael J. Katovich, Vinayak Shenoy
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2018-03-01
coleção:	Frontiers in Physiology
Assuntos:	pulmonary fibrosis pulmonary hypertension C21 AT2 receptor bleomycin rats
Acesso em linha:	http://journal.frontiersin.org/article/10.3389/fphys.2018.00180/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!